Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer
Completed · Phase 2
Conditions studied: Kidney Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy used to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy followed by donor peripheral stem cell transplantation in treating patients who have metastatic or unresectable kidney cancer.
Key facts
- Study ID
- NCT00027573
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 36
- Starts
- 2001-10-01
- Expected to finish
- 2006-06-01
- Last updated by the study team
- 2016-07-14
Who can join
Age: any, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CCOP - Mayo Clinic Scottsdale Oncology Program — Scottsdale, Arizona, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- CCOP - Northern New Jersey — Hackensack, New Jersey, United States
- CCOP - Oklahoma — Tulsa, Oklahoma, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.